A detailed history of Russell Investments Group, Ltd. transactions in Ocugen, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 3,176 shares of OCGN stock, worth $2,636. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,176
Holding current value
$2,636
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.98 - $1.95 $3,112 - $6,193
3,176 New
3,176 $3,000
Q1 2023

May 09, 2023

SELL
$0.82 - $1.33 $3,494 - $5,668
-4,262 Reduced 93.79%
282 $0
Q3 2022

Nov 04, 2022

SELL
$1.75 - $3.1 $2,448 - $4,336
-1,399 Reduced 23.54%
4,544 $8,000
Q4 2021

Jan 21, 2022

SELL
$4.38 - $15.67 $113,148 - $404,803
-25,833 Reduced 81.3%
5,943 $27,000
Q3 2021

Nov 08, 2021

BUY
$6.36 - $8.51 $202,095 - $270,413
31,776 New
31,776 $228,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $180M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.